At the conclusion of its 4 year duration to enhance the safety and efficacy of medical procedures involving ionising radiation, the SINFONIA project releases its recommendations on personalised dosimetry and risk assessment in diagnostic radiology, nuclear medicine and radiation therapy during management of patients with lymphoma or brain tumour. The project’s multidisciplinary approach has led to significant advancements in radiation protection measures.
Ionising radiation, while crucial in medical diagnostics and treatment, poses significant risks, including cancer and other health issues. The consortium has developed AI tools for precise, patient-specific dose estimations, such as the i-Dose platform, which optimises X-ray procedures. Advances have also been made in low-dose determinations for radiation therapy. The project emphasises the importance of education and training in radiation safety, equipping medical professionals with the tools and knowledge to enhance patient care. The recommendations highlight the need for effective radiation protection practices, especially for patients with serious or confirmed cancer diagnoses.
Additionally, the project addressed the risks associated with radionuclide production and administration by developing models to assess the impact on humans and the environment. AI and machine learning are expected to further reduce radiation doses and improve image quality in the future. The recommendations mark a significant step forward in the safe use of ionising radiation in medical settings.
Visit the project website for more information, or read the recommendations document below.
SINFONIA_recs